How Do I Know If I Have Heart Problems?

Heart problems announce themselves through a wide spectrum of signals, from the dramatic crushing chest pain most people picture to vague fatigue or breathlessness that develops so gradually you barely notice it. The challenge is that no single symptom reliably confirms or rules out cardiac disease. Some people walk around with dangerously narrowed coronary arteries and feel nothing at all, while others rush to the emergency room with chest tightness that turns out to be acid reflux. Sorting out which signals deserve urgent attention, which warrant a calm conversation with your doctor, and which tests actually move the needle is the real skill here.

The Classic Warning Signs

The textbook heart-attack presentation is pressure or squeezing in the center of the chest, sometimes radiating to the left arm, jaw, or back, often accompanied by sweating, nausea, or lightheadedness. Research confirms that classic chest symptoms and sweating (diaphoresis) are strong independent predictors of coronary heart disease in people without diabetes.¹ That same study found, however, that in people with diabetes those supposedly diagnostic symptoms lose much of their predictive power. Diabetes can blunt the nerve signals that produce chest pain, making a heart attack harder to recognize from symptoms alone.

Beyond acute events, chronic heart disease tends to show up as exertional breathlessness, unusual fatigue with activity you used to handle easily, swelling in the ankles or feet, or a heartbeat that feels irregular or unusually fast. Heart failure in particular produces a constellation that includes difficulty breathing while lying flat, fluid retention, and fatigue that worsens over days or weeks. These signs often creep in slowly enough that people attribute them to aging or being out of shape.

Why Symptoms Look Different in Women

One of the most clinically important findings of the past two decades is that women having a heart attack often present differently from men. A review of myocardial infarction symptoms across sexes found that while chest, arm, and jaw pain remained the most common complaints for both men and women, women presented with more “atypical” symptoms such as nausea, vomiting, and shortness of breath. Women also reported more prodromal symptoms like fatigue in the days leading up to the event, took longer to get to a hospital after symptoms started, and were older with more comorbidities at the time of the event.²

A separate study looking specifically at acute coronary syndromes confirmed that men were more likely to present with chest pain, left arm pain, or sweating, while nausea was more common in women. After adjusting for differences in age and other health conditions, the gender gap in chest pain and arm pain largely disappeared, but the differences in sweating and nausea persisted as something tied to sex itself rather than to comorbidities.³ The practical takeaway: if you are a woman experiencing unexplained nausea, new-onset fatigue, or sudden breathlessness, those warrant the same urgency as chest pain would in a man. Interestingly, men are actually more likely to have a completely silent or unrecognized heart attack, which contributes to their overall higher rate of cardiac events.²

Silent Heart Disease

Perhaps the most unsettling answer to “how do I know if I have heart problems” is that you might not know. A study of asymptomatic patients with no prior coronary artery disease diagnosis found that about 21% had silent ischemia on stress imaging, and 6% had high-risk ischemia. Those with high-risk silent ischemia had a substantially worse prognosis, with a hard-event rate of roughly 3% compared to 0.4% in those with less severe findings.⁴ In other words, a meaningful fraction of people who feel perfectly fine already have reduced blood flow to the heart muscle.

Silent ischemia is especially common in people with diabetes, older adults, and those with longstanding high blood pressure. Because you cannot rely on symptoms to alert you, these populations benefit most from periodic screening, risk-factor management, and honest conversations with their doctors about whether further testing is warranted even in the absence of complaints.

What an ECG Can and Cannot Tell You

The electrocardiogram, or ECG, is usually the first test ordered when heart trouble is suspected. It is quick, cheap, painless, and widely available. But its ability to catch heart problems varies enormously depending on what you are looking for. For detecting a prior heart attack, one study found the ECG had a sensitivity of only about 38%, meaning it missed more than half of confirmed previous heart attacks, though its specificity was around 87%, meaning a positive reading was fairly reliable.⁵

For stable coronary artery disease, the picture is even less reassuring. A study of patients with confirmed coronary disease found that roughly half had a completely normal resting ECG, and the sensitivity of the resting ECG for detecting typical ischemic patterns was only about 23% overall. Among those with a normal tracing, more than half still had significant narrowing in at least one major coronary artery.⁶ An evidence review concluded that for individual ECG abnormalities, the sensitivity for predicting future cardiac events was too low for the ECG to serve as a practical screening tool on its own.⁷

This does not mean the ECG is useless. It is excellent for identifying active heart attacks (ST-elevation patterns), certain rhythm disorders, and conduction problems. The key point is that a normal ECG does not rule out heart disease. If your symptoms or risk factors are concerning, a normal tracing should not be taken as an all-clear.

Blood Tests That Flag Heart Trouble

Two blood markers dominate cardiac diagnostics. Troponin is the gold-standard biomarker for heart-muscle injury. When heart cells are damaged or dying, they release troponin into the bloodstream, and modern high-sensitivity assays can detect even small amounts. Elevated troponin levels are used to diagnose acute heart attacks but also carry prognostic information in heart failure. In acute decompensated heart failure, elevated troponin has repeatedly been shown to correlate with higher short- and long-term mortality.⁸ Worth noting: troponin can rise from causes other than a classic heart attack, including severe infections, kidney failure, pulmonary embolism, and even extreme endurance exercise. An elevated result always requires clinical context.

B-type natriuretic peptide (BNP) and its precursor NT-proBNP are released when the heart is under stretch or pressure overload. These markers are particularly useful for diagnosing heart failure: if you show up to an emergency room short of breath and your BNP is low, heart failure is unlikely. If it is high, further workup is warranted.⁹ Neither troponin nor BNP is something you order on yourself; your doctor requests them when symptoms, exam findings, or other test results raise suspicion. But understanding what they measure can help you ask smarter questions when the results come back.

Stress Tests and Imaging

When a resting ECG is not enough, the next step is often a stress test, which monitors your heart under exertion, either on a treadmill or with medication that simulates exercise. A head-to-head comparison of stress echocardiography methods found that exercise stress echo had sensitivity of about 88% and specificity of 82% for detecting ischemia, while drug-based alternatives (dobutamine and dipyridamole) had somewhat lower sensitivity but in one case higher specificity.¹⁰ In practice, exercise-based tests are preferred whenever you are physically able to exercise, because they also provide useful information about your fitness level and blood-pressure response.

Echocardiography (ultrasound of the heart) is the workhorse of cardiac imaging. It shows the heart’s structure and pumping function in real time, without radiation. For structural problems like valve disease, weakened heart muscle, or fluid around the heart, it is often the first and only imaging study needed. Cardiac CT is a complementary tool that excels at visualizing the coronary arteries themselves and is especially good at identifying calcium deposits that signal atherosclerosis. In congenital heart disease, echocardiography and CT have been shown to be complementary: echo is preferred for abnormalities inside the heart, while CT provides better visualization of structures outside it.¹¹ For most adults being evaluated for coronary disease, a coronary CT angiogram has become a common non-invasive first step before anyone considers a catheterization.

When Chest Pain Is Not Your Heart

Most chest pain evaluated in emergency settings turns out not to be cardiac. The three biggest non-cardiac culprits are gastrointestinal, musculoskeletal, and psychiatric. A systematic review of diagnostic indicators for non-cardiovascular chest pain found that gastroesophageal reflux disease (GERD) was the most studied alternative diagnosis. Classic GERD symptoms like heartburn and acid regurgitation made the diagnosis more likely, and a positive response to a short course of acid-suppressing medication was a reasonably strong diagnostic signal.¹²

Musculoskeletal chest pain, from strained muscles, costochondritis, or rib issues, tends to be reproducible with movement or pressing on the chest wall, though clinical exam findings for it are imperfect. Anxiety and panic disorder can produce chest tightness, racing heart, and a sense of doom that closely mimics cardiac events. The same review noted that screening tools for anxiety and panic disorder can help identify patients who need psychiatric rather than cardiac workup.¹² None of this means you should self-diagnose your chest pain as “just anxiety” or “just reflux.” The point is that your doctor has tools to sort these apart, and the process of ruling out cardiac causes is a normal and expected part of the evaluation.

Catching Intermittent Problems With Extended Monitoring

Some heart problems only show up sporadically. Arrhythmias in particular may occur for seconds or minutes and then disappear, making them invisible to a standard ECG or even a 24-hour Holter monitor. Research has consistently shown that longer-duration monitoring dramatically improves detection. A comparison of 24-hour Holter monitoring versus a 14-day wearable ECG patch found that the patch detected paroxysmal arrhythmias in 66% of patients, compared to just 9% with the Holter.¹³

A separate study comparing 7-day patch monitoring to 24-hour Holter found a similar pattern: overall arrhythmia detection was about 35% with the 7-day patch versus 19% with the Holter.¹⁴ For atrial fibrillation specifically, a large study found patch-ECG detection rates of about 24% versus 12% with Holter, and while a substantial portion of atrial fibrillation episodes were caught on the first day, diagnosis rates continued to climb steadily through day 14.¹⁵ If you have episodes of palpitations, dizziness, or unexplained fainting and a 24-hour Holter was normal, asking your doctor about longer-term monitoring is reasonable.

What Smartwatches Can and Cannot Do

Consumer wearable devices have entered the cardiac screening conversation in a serious way, particularly for atrial fibrillation. A systematic review and meta-analysis of smartwatch accuracy found pooled sensitivity of about 95% and specificity of 97% for atrial fibrillation detection, with an area under the curve of 0.97.¹⁶ Performance varied by brand, but all the major devices tested well. The accuracy was comparable whether the watch used an optical sensor on the wrist or a single-lead ECG built into the device.

These numbers are impressive in a research setting, but real-world performance comes with caveats. Most of the studies evaluated the watches against a confirmed ECG reading, meaning the watch was tested on people who already had or did not have the arrhythmia. In everyday use, the vast majority of people wearing smartwatches do not have atrial fibrillation, and when a rare condition is being screened for in a huge low-risk population, even a test with 97% specificity will produce many false alarms for every true positive. A smartwatch alert for an irregular rhythm deserves follow-up with a medical-grade ECG, not panic. And current smartwatches are not designed to detect most other forms of heart disease, including coronary artery blockages, valve problems, or heart failure.

Inflammatory Markers and Long-Term Risk

Beyond troponin and BNP, which signal acute problems, a separate category of blood markers helps estimate your long-term risk of developing heart disease. High-sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation, has emerged as one of the strongest predictors. A landmark study in women found that hs-CRP was the strongest single predictor of future cardiovascular events among 12 markers tested: women in the highest quarter for hs-CRP had roughly four times the risk of events compared to those in the lowest quarter.¹⁷ Models combining inflammatory markers with traditional lipid levels performed significantly better than lipid-based models alone.

More recent work has extended these findings over longer time horizons. A 30-year follow-up study found that hs-CRP, LDL cholesterol, and lipoprotein(a) each independently predicted cardiovascular events, and models incorporating all three biomarkers provided the widest spread for distinguishing high-risk from low-risk individuals.¹⁸ In a large national cohort, the ratio of hs-CRP to HDL cholesterol was independently associated with cardiovascular disease risk in middle-aged and older adults.¹⁹ Hs-CRP is not yet part of routine screening for everyone, but if you have borderline risk factors and your doctor is on the fence about whether to start treatment, an hs-CRP level can help tip the decision.

Family History and Genetic Testing

A family history of early heart disease, typically defined as a first-degree relative who had a cardiac event before age 55 (for men) or 65 (for women), is one of the strongest risk factors you cannot modify. It signals both shared genetic susceptibility and shared environmental exposures. For certain inherited cardiovascular conditions, including cardiomyopathies, inherited arrhythmia syndromes, and familial hypercholesterolemia, genetic testing has become a meaningful clinical tool. The American Heart Association has issued guidance outlining current best practices for genetic testing in these conditions.²⁰

The most direct benefit of identifying a causative genetic variant is cascade testing: once a pathogenic mutation is found in one family member, close relatives can be tested for that specific variant. Those who carry it can begin surveillance or preventive treatment before symptoms appear. Those who do not carry it can be reassured and spared unnecessary lifelong monitoring.²¹ Genetic testing is not useful for the majority of common heart disease, which is driven by dozens or hundreds of small-effect genetic variants interacting with lifestyle. But for families with unexplained sudden cardiac death, early-onset heart failure, or dramatically high cholesterol levels, it can be transformative.

Conditions That Mimic or Complicate the Picture

Not all heart problems trace back to clogged arteries. A substantial number of patients with chest pain or angina symptoms turn out to have clean coronary arteries on angiography. Many of these patients have coronary microvascular dysfunction, where the tiny blood vessels within the heart muscle do not dilate properly. This condition causes real cardiac ischemia, real symptoms, and real long-term risk, but it is invisible on a standard angiogram because the affected vessels are too small to see.²² If you have been told your arteries are clear but you still have symptoms, microvascular disease is worth discussing with a cardiologist who specializes in it.

Takotsubo cardiomyopathy, sometimes called broken-heart syndrome, is another condition that mimics a heart attack. Triggered by intense emotional or physical stress, it causes temporary ballooning and weakening of part of the heart muscle, often in postmenopausal women. It can produce chest pain, elevated cardiac enzymes, and ECG changes that look like a heart attack, but coronary angiography typically shows no blockages.²³ The heart usually recovers within weeks, but the acute phase can be dangerous.

Myocarditis, or inflammation of the heart muscle, can follow viral infections including common respiratory and gastrointestinal bugs. The clinical presentation ranges from barely noticeable fatigue to acute heart failure or sudden cardiac death. Cardiac MRI has proven capable of detecting early myocardial involvement even after apparently minor infections.²⁴ New or worsening chest pain, unexplained shortness of breath, or palpitations in the weeks following a viral illness deserve medical evaluation, particularly if you are young and otherwise healthy, a group where myocarditis has an outsized impact relative to atherosclerotic disease.²⁵

Environmental Triggers You Might Not Expect

Heart problems do not only come from inside your body. Short-term exposure to fine particulate air pollution has been linked to acute coronary events. A study found that a modest increase in fine particulate matter (PM2.5) was associated with a roughly 4.5% increase in the risk of unstable angina and heart attack, with the greatest impact on people who already had underlying coronary artery disease.²⁶ This means that high-pollution days, wildfire smoke events, and heavily trafficked areas pose measurable cardiac risk, especially for those who already have narrowed arteries or other risk factors. Practical steps like checking air-quality indices, reducing outdoor exertion on high-pollution days, and using air filtration indoors are evidence-supported ways to lower that exposure.